Fundraising Fox

Atreca

Redwood City, US · Delaware corporation · 5 known investors

atreca.com ↗
Biotech

Founders & leadership

WR
William RobinsonCo-founder
LS
Lawrence SteinmanCo-founder
TS
Tito SerafiniCo-founder

Board

BA
Brian AtwoodBoard director
FB
Franklin BergerBoard director

Investors · 5

Aisling CapitalNew York
EcoR1 CapitalSan Francisco
Mission Bay CapitalSan Francisco
Mission BiocapitalSan Francisco · $500K

Also in the syndicate · 1

Strategic Investment Fund

Funding

SEC filings, press & company announcements

$217.3M disclosed across 3 of 5 rounds · 2015–2026

  • Undisclosed amountSeries AFeb 2026

    Strategic Investment Fund

    Source ↗
▶$125MraisedSep 2018 · 43 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William RobinsonDirector
  • Susan BerlandExecutive Officer
  • John OrwinExecutive Officer, Director
  • David LaceyDirector
  • Franklin BergerDirector
  • Brian AtwoodDirector
  • Tito SerafiniExecutive Officer, Director
  • Lawrence SteinmanDirector
Offering amount
$125M
Amount sold
$125M
Sales commissions
$4.5M
Placement agents
Cowen and Company, LLC
First sale
Sep 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$35MraisedDec 2017 · 71 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence SteinmanDirector
  • Brian AtwoodDirector
  • David LaceyDirector
  • Susan BerlandExecutive Officer
  • Tito SerafiniExecutive Officer, Director
  • William RobinsonDirector
  • Franklin BergerDirector
Offering amount
$35M
Amount sold
$35M
Sales commissions
$390.3K
Placement agents
CIM SECURITIES, LLC
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$723KofferedDec 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William RobinsonDirector
  • Lawrence SteinmanDirector
  • Tito SerafiniExecutive Officer, Director
  • Franklin BergerDirector
  • Brian AtwoodDirector
Offering amount
$723K
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$57.3MraisedDec 2015 · 88 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian AtwoodDirector
  • Tito SerafiniExecutive Officer, Director
  • Franklin BergerDirector
  • Lawrence SteinmanDirector
  • William RobinsonDirector
Offering amount
$57.3M
Amount sold
$57.3M
Sales commissions
$2.7M
Placement agents
Brookline Group, LLC
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Atreca - Strategic Investment Fundsif.gatesfoundation.org · Feb 2026Immunome Announces Completion of Purchase of Assets from Atreca - Investor Relationsinvestors.immunome.com · May 2024Atreca, facing Q1 funding cliff edge, cuts head count by 40% for 2nd time in 3 monthsfiercebiotech.com · Nov 2023GSK-backed Atreca inks license with Gates Medical Research Institute for malaria monoclonal antibody | Fierce Biotechfiercebiotech.com · Oct 2021Atreca Raises $125M in Series C Funding - FinSMEsfinsmes.com · Sep 2018Bay Area's Atreca Reels in $56 Million Series A Funding to Advance Pipeline of Novel Cancer Immunotherapies - BioSpacebiospace.com · Nov 2015

Frequently asked questions

Who founded Atreca?
Atreca was founded by William Robinson, Lawrence Steinman, Tito Serafini.
Who are Atreca's investors?
Atreca's investors include Aisling Capital, EcoR1 Capital, Mission Bay Capital, Mission Biocapital.
How much funding has Atreca raised?
Atreca has disclosed $217.3M raised across 3 of its 5 known rounds.
Where is Atreca headquartered?
Atreca is headquartered in Redwood City, US.